Nm. Wang et al., Immunologic characterization of a recombinant American cockroach (Periplaneta americana) Per a 1 (Cr-PII) allergen, ALLERGY, 54(2), 1999, pp. 119-127
Background: Previously, we have identified several Per a 1 (CrPII) allergen
s from a lambda gt22A cDNA library of Periplaneta americana. This study aim
ed to sequence clone C42 and determine its molecular and antigenic properti
es.
Methods: The cDNA of C42 was sequenced and ligated into a bacteria expressi
on vector, pET21. The recombinant proteins were purified by ion-exchange an
d affinity chromatographies. Their antigenicities were analyzed by immunobl
otting, ELISA, and binding inhibition with human IgE.
Results: The nucleotide of the cDNA has been sequenced and the deduced amin
o acid which encodes a 446-amino-acid protein (50kDa) determined. The recom
binant C42 protein can bind both anti-Per a 1 monoclonal antibodies and hum
an IgE and showed a 54.4% (12/22) skin reactivity in atopic patients. Seque
nce homology searches revealed a high degree of identity to two other membe
rs of the Per a 1 family, C17 and C6, and the German cockroach (Blattella g
ermanica) Bla g Bd90K allergen. Interestingly, these allergens all contain
internal repeals, and the crude B. germanica extract, Per a 1, and recombin
ant allergens share similar antigenic determinant(s) as defined by ELISA an
d IgE-binding inhibition studies. In IgE-binding epitope studies, an immuno
positive C42 fragment was first identified from partial protease digestion.
Overlapping peptides were then generated by expression of restriction enzy
me fragments in E. coil. The shortest peptide, C42-P560, identified by mono
clonal antibodies and human specific IgE, can inhibit IgE binding to C42.
Conclusions: An additional Per a 1 allergen has been defined at the molecul
ar level and characterized and preliminary results showed that a potential
IgE-reactive region is located within amino-acid residue 358-446 of C42, wh
ich is an internal repeat. The results defined the boundaries of the antige
nic site and will facilitate further epitope-mapping studies.